Intravenous lipid emulsion therapy for flecainide toxicity

  • Mullins M
  • Miller S
  • Nall C
  • et al.
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

ABSTRACTIntravenous lipid emulsion (ILE) is an accepted antidote for systemic local anesthetic toxicity and may be useful for other lipophilic drugs with cardiac toxicity. Flecainide is a class IC antiarrhythmic drug related to lidocaine. Flecainide is highly lipophilic with an octanol/water partition coefficient of 3.8 (similar to that of bupivacaine). In overdose, flecainide produces wide complex dysrhythmias and cardiogenic shock. We describe two patients with life-threatening flecainide overdoses which were refractory to standard treatment and which responded rapidly to ILE. Patient 1 was a 49-year-old man who had bradycardia (31 bpm) and hypotension (50 mmHg systolic) after taking 2400 mg of flecainide. His ECG showed a wide complex bradycardia (QRS 178 ms). Bradycardia and hypotension persisted despite atropine, glucagon, CPR, endotracheal intubation, epinephrine, dopamine, magnesium sulfate, and sodium bicarbonate. Patient 2 was a 69-year-old man who ingested 1 g of flecainide, 12 mg of clonazepam,...

Cite

CITATION STYLE

APA

Mullins, M. E., Miller, S. N., Nall, C. E., & Meggs, W. J. (2017). Intravenous lipid emulsion therapy for flecainide toxicity. Toxicology Communications, 1(1), 34–36. https://doi.org/10.1080/24734306.2017.1405546

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free